Surveillance of emerging infectious diseases and identification of causative pathogens

Monitoring of Emerging Infectious Diseases and Identification of Causative Pathogens

Operation of a monitoring system for samples and supplementary pathogens to identify the outbreak and emergence of variants of respiratory infectious diseases (such as influenza, COVID-19, and 9 other types) (Targets) Individuals with respiratory symptoms in the community, high-risk groups (severe patients, elderly), and individuals with respiratory symptoms among incoming travelers
Operation of a symptom-based surveillance system for unidentified causes where the causative pathogen has not been identified (Symptoms) Respiratory, neurological, gastrointestinal symptoms, etc.
Surveillance of respiratory virus genomes based on next-generation sequencing (NGS) Surveillance targets for samples and complementary pathogens, such as community sewage and wastewater at airports and seaports

Development of targeted diagnostic methods for infectious disease pathogens that are not currently occurring domestically but have the potential to enter
Development of symptom and family-based diagnostic methods that can simultaneously test multiple pathogens (including NGS and PCR technologies)